AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,511,000 | -28.3% | 468,152 | -13.0% | 0.15% | -12.0% |
| Q1 2022 | $4,897,000 | +46.1% | 538,152 | +12.7% | 0.17% | +69.4% |
| Q4 2021 | $3,352,000 | -28.4% | 477,450 | +16.2% | 0.10% | -32.9% |
| Q3 2021 | $4,683,000 | -2.5% | 410,766 | +36.9% | 0.15% | -1.4% |
| Q2 2021 | $4,804,000 | -20.7% | 300,091 | -11.5% | 0.15% | -26.4% |
| Q1 2021 | $6,058,000 | -5.4% | 338,985 | -28.5% | 0.20% | -10.3% |
| Q4 2020 | $6,402,000 | +29.7% | 473,898 | +13.0% | 0.22% | +2.3% |
| Q3 2020 | $4,935,000 | +36.0% | 419,251 | +70.5% | 0.22% | +25.1% |
| Q2 2020 | $3,628,000 | +170.9% | 245,833 | +147.9% | 0.18% | +101.1% |
| Q1 2020 | $1,339,000 | +11.6% | 99,166 | +99.8% | 0.09% | +55.4% |
| Q4 2019 | $1,200,000 | -91.0% | 49,637 | -82.3% | 0.06% | -92.6% |
| Q1 2019 | $13,337,000 | – | 280,778 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |